Detalles de la búsqueda
1.
Beta subunits promote K+ channel surface expression through effects early in biosynthesis.
Neuron
; 16(4): 843-52, 1996 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-8608002
2.
Cloning, mRNA localization and evolutionary conservation of a human 5-HT7 receptor pseudogene.
Gene
; 227(1): 63-9, 1999 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-9931439
3.
The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease.
Curr Pharm Des
; 8(2): 139-45, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11812255
4.
Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
Neuropharmacology
; 33(3-4): 423-31, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7984280
5.
Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study.
Br J Pharmacol
; 130(4): 797-804, 2000 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-10864885
6.
Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
Biochem Pharmacol
; 40(7): 1541-50, 1990 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-2222509
7.
Identification of a human 5-HT6 receptor variant produced by alternative splicing.
Brain Res Mol Brain Res
; 64(2): 255-63, 1999 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-9931499
8.
1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats.
Psychopharmacology (Berl)
; 94(3): 342-6, 1988.
Artículo
en Inglés
| MEDLINE | ID: mdl-3128809
9.
Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes.
Eur J Pharmacol
; 291(1): 9-15, 1995 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-8549648
10.
[3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
Eur J Pharmacol
; 198(1): 59-67, 1991 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-1680714
11.
Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation.
Eur J Pharmacol
; 172(6): 497-500, 1989 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-2533081
12.
Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways.
Naunyn Schmiedebergs Arch Pharmacol
; 348(6): 566-75, 1993 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-8133900
13.
Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
Naunyn Schmiedebergs Arch Pharmacol
; 354(3): 226-36, 1996.
Artículo
en Inglés
| MEDLINE | ID: mdl-8878051
14.
Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer.
J Pharmacol Toxicol Methods
; 40(1): 47-55, 1998 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-9920534
15.
Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
J Psychopharmacol
; 16(2): 145-52, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12095073
16.
Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
Neuropharmacology
; 66: 202-14, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22551786
17.
Concomitant blockade of 5-HT(1A) receptor and 5-HT transporter: use of the Hunter Serotonin toxicity criteria in a clinical pharmacology study.
Eur Neuropsychopharmacol
; 22(2): 92-9, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21733663
18.
Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?
Eur J Pharmacol
; 171(1): 137-9, 1989 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-2612568
19.
Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant.
Br J Pharmacol
; 157(2): 307-19, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19338583
20.
Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
J Pharmacol Exp Ther
; 314(3): 1274-89, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15951399